Content area

|
|

Behandling af synstruende diabetisk retinopati

Forfatter(e)
Jakob Grauslund1, 2 1) Øjenafdeling E, Odense Universitetshospital 2) Forskningsenheden for Oftalmologi, Klinisk Institut, Syddansk Universitet Ugeskr Læger 2018;180:V11170870
Reference: 
Ugeskr Læger 2018;180:V11170870
Sidetal: 
2-5
Treatment of sight-threatening diabetic retinopathy
In diabetic retinopathy, treatment is indicated for sight-threatening complications like proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DME). For decades, treatment has been with panretinal laser for PDR and focal/grid laser for DME. In recent years, intravitreal therapy with vascular endothelial growth factor (VEGF) inhibition or steroids has replaced laser treatment in centre-involving DME. Intravitreal VEGF-inhibition has also demonstrated effectiveness in PDR, but long-term studies are needed to address the concern of a potential continuous treatment burden.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Sandra Maria Skovdal | 20/03
28 kommentarer
af Christian F. Asmussen | 19/03
7 kommentarer
af Benedicte Vibjerg Wilson | 19/03
1 Kommentar
af Niels Foldager | 19/03
1 Kommentar
af Stig Gerdes | 18/03
4 kommentarer
af Gorm Greisen | 17/03
1 Kommentar
af Lars Erik Larsen | 17/03
5 kommentarer
af Frede Simonsen | 13/03
1 Kommentar
af Bo Hasseriis Hansen | 13/03
5 kommentarer